The origin and fate of some tyrosine secondary metabolites within spec
ialized eukaryotic cells are discussed in the light of our knowledge o
f the plasma environment to which they are exposed throughout their li
fetime. Attention is focused on ar-dihydroxy and -trihydroxy derivativ
es and the corresponding quinoidal counterparts, as well as on the enz
ymic activities involved in the formation and degradation of these pot
entially toxic molecules. Some physiopathological and pharmacological
implications of the above-mentioned topics are considered, taking into
account the well known toxicity of reactive intermediates in molecula
r oxygen reduction, as well as the reactivity of both semiquinonic and
quinonic products of catecholamine oxidation. (C) 1998 Elsevier Scien
ce Inc.